VC
Vaccinex, Inc.
VCNX · OTC
$1.00 +0.00% (+$0.00)
1M -4.76%
Market Cap $2.68M
P/E Ratio -
Div. Yield -
ROE -
Piotroski F-Score Moderate
4/9Valuation
40 /100
Fair P/S 4.45x
PEG N/A
P/E N/A
Growth
0 /100
Declining Rev. growth 12.59%
Book val. growth N/A
EPS growth N/A
Profitability
20 /100
Weak Op. margin 3,117.30%
Gross margin 95.51%
FCF margin 2,696.84%
Quality
61 /100
Average Asset turnover 0.23x
ROIC 760.66%
ROA 717.80%
Debt
3 /100
High Int. coverage -620.13x
Current ratio 0.50x
Debt/Assets N/A
Stability
52 /100
Moderate EPS volatility 19.97%
Beta 0.68x
Profitable years 0
Bulios Scoring opisuje jakość i historię firmy, a nie przyszły zwrot. Wysoki wynik to nie sygnał zakupu. Dowiedz się więcej
Zapytaj StockBota o VCNX
Online
Sector
Healthcare
Industry
Biotechnology
CEO
Maurice Zauderer
Employees
25
Headquarters
Rochester
Nadchodzące wydarzenia
16 LIS
Earnings
Upcoming earnings report